proteins as molecular markers in the diagnosis of cervical oncopathology.
Materials and Methods. A
Lin, Jianjun,
Lin, Ke,
Huang, Lijiang,
Jiang, Yongsheng,
Ding, Xiaoxiao,
Luo, Wu,
Samorodov, Aleksandr V.,
Pavlov, Valentin N.,
Liang, Guang,
Qian, Jianchang,
Wang, Yi (2022) with TLR4 and its adaptor
protein myeloid differentiation
protein 2 (MD2). Genetic loss of MD2 ameliorates
Dorling, L.,
Carvalho, S.,
Allen, J.,
González-Neira, A.,
Luccarini, C.,
Wahlström, C.,
Pooley, K.A.,
Parsons, M.T.,
Fortuno, C.,
Wang, Q.,
Bolla, M.K.,
Dennis, J.,
Bermisheva, M.,
Khusnutdinova, E.,
Prokofyeva, D.,
other additional authors (2021) . In separate analyses for
protein-truncating variants and rare missense variants in these genes, we estimated
Kayumova, R.R.,
Sultanbaev, A.V.,
Ostakhov, S.S.,
Khursan, S.L.,
Abdullin, M.F.,
Gantsev, S.K.,
Sakaeva, D.D. (2017) solutions of tryptophan (Trp) (total concentration is 1.0 × 10−5 mol L−1, λmax = 353 nm) and plasma
proteinClaudins are a tetraspan membrane
protein multigene family that plays a structural and functional
of polymorphic variants of inflammation genes with MetS and serum levels of high-sensitivity C-reactive
protein